FCRL1 and diffuse large B-cell lymphoma: This notion is further confirmed by the findings of Zahra et al., who revealed that FcRL1-KO significantly reduced cell proliferation, enhanced the apoptosis, and triggered the G1 cell cycle arrest in B-cells derived from diffuse large B-cell lymphoma (DLBCL) patients.